Chronic anemia in inflammatory bowel diseases: Review;L'anémie chronique dans les maladies inflammatoires de l'intestin: Revue de littérature

Revue Medicale de Liege

Volumn 60, Issue 11, 2005, Pages 888-892

  Vijverman, A ^a   Belaiche, J ^a   Louis, E ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Chronic anemia; Inflammatory bowel disease; Management

Indexed keywords

DEXTRAN; ERYTHROPOIETIN; FERRIC HYDROXIDE SUCROSE; INFLIXIMAB; INTERLEUKIN 1; INTERLEUKIN 6; RECOMBINANT ERYTHROPOIETIN; TUMOR NECROSIS FACTOR ALPHA;

ALGORITHM; ANEMIA; BURST FORMING UNIT; CHRONIC INFLAMMATION; COLONY FORMING UNIT; ENTERITIS; HUMAN; REVIEW; TREATMENT OUTCOME;

ANEMIA; CHRONIC DISEASE; HUMANS; INFLAMMATORY BOWEL DISEASES; QUALITY OF LIFE;

EID: 29344441681     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Gasche C, Reinisch W, Lochs H, et al.- Anemia in Crohn's disease. Importance of inadequate erythropoietin production and iron deficiency. Dig Dis Sci, 1994, 39, 1930-34
2. Gasche C.- Anemia in IBD: The Overlooked Villain. Inflamm Bowel Dis, 2000, 6, 142-150
3. Krantz SB.- Erythropoietin and the anemia of chronic disease. Nephrol Dial Transplant, 1995, 10, 10-7
4. Evans RW, Rader B, Manninen DL.- The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. Cooperative Multicenter EPO Clinical Trial Group. JAMA, 1990, 263, 825-30
5. Grimm G, Stockenhuber F, Scheeweiss B, et al.- Improvement of brain function in hemodialysis patients treated with erythropoietin. Kidney Int, 1990, 38, 480-6
6. Leitgeb C, Pecherstorfer M, Fritz E, et al.- Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin. Cancer, 1994, 73, 2535-42
7. Best WR, Becktel JM, Singleton JW.- Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI). Gastroenterology, 1979, 77, 843-6
8. Gasche C, Dejaco C, Waldhoer T, et al.- Intravenous iron and erythropoietin for anemia associated with Crohn's disease. Ann Intern Med, 1997, 126, 782-787
9. Mac dougall IC.- Quality of life and anemia: the nephrology experience. Semin Oncol, 1998, 25, 39-42
10. Macdougall IC.- Srategies for iron supplementation: oral versus intraveinous. Kidney int, 1999, 69, s61-s66
11. Beal RW, Skyring AP, McRae J, et al.- The anemia of ulcerative colitis. Gastroenterology, 1963, 45, 589-603
12. Both H, Trop-Pedersen K, Kreiner S, et al.- Clinical appearance at diagnosis of ulcerative colitis and Crohn's disease in a regional patient group. Scan J Gastroenterol, 1983, 18, 987
13. Ormerod TP.- Observation on the incidence and cause of anemia in ulcerative colitis. Gut, 1967, 8, 107-114
14. Schreiber S, Howaldt S, Schnoor M, Net al.- Erythropoietin for inflammatory bowel disease anemia. Gastroenterology, 1997, 112,660-665
15. Mahida YR, Wu K, Jewell DP.- Enhance production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis or Crohn's disease.Gut, 1989, 30, 835-8
16. MacDonald TT, Hutchings P, Choy MY, et al.- Tumor necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed humane intestine. Clin Exp Immunol, 1990, 81, 301-305
17. Tilbrook PA, Klinken SP.- The erythropoietin receptor. Int J Biochem Cell Biol, 1999, 73, 2535-42
18. Child JA, Broezvic B, Dyer NH, et al.- The diagnosis of iron deficiency in patients with Crohn's disease. Gut, 1973, 14, 642-8
19. Bartels U, Pedersen NS, Jarnum S.- Iron absorption and serum ferritin in chronic inflammatory bowel disease. Scan J Gastroenterol, 1978, 13, 649-56
20. Thomson ABR, Brust R, Ali MAN, et al.- Iron deficiency in inflammatory bowel disease. Am J Dig Dis, 1978, 23, 705-709
21. PunnonenK, Irjala K, Rajamaki A.- Serum transferring receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood, 1997, 89, 1052-7
22. Ligumsky M, Simon PL, Karmeli F, et al.- Role of interleukin Iβ in inflammatory bowel disease- enhanced production during active disease. Gut, 1990, 31, 686-9
23. Reinecker HC, Steffen M, Witthoeft T, et al.- Enhanced secretion of tumor necrosis factor a, IL6, and ILIβ by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol, 1990, 81, 301-5
24. Horina HJ, Petritsch W, Schmid CR, et al.- Treatment of anemia in inflammatory bowel disease with recombinant human erythropoietin: results in three patients. Gastroenterology, 1993, 104, 1828-31
25. Means RTJ, Krantz SB.- Progress in understanding the pathogenesis of the anemia of chronic disease. Blood, 1992,80, 1639-47
26. Means RT Jr.- Advances in the anemia of chronic disease. Int J Hematol, 1999, 70, 7-12
27. Macdougal IC, Cavill I, Hulme B, et al.- Detection of functional iron deficiency during erythropoietin treatmen: a new approach. BMJ, 1992, 304, 225-6
28. Means RTJ, Dessypris EN, Krantz SB.- Inhibition of human erythroid colony-forming units by interleukin is mediated by interferon. J Cell Physiol, 1992,150, 59-64
29. Fanquin WC, Schneider TJ, Goldberg MA.- Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood, 1992, 79, 1987-1994
30. Eschbach JW, Adamson JW- Guidelines for recombinant human erythropoietin therapy. Am J Kidney Dis, 1989,14,2-8
31. Baer AN, Dessypris EN, Goldwasser E, et al.- Blunted erythropoietin response to anaemia in rheumatoid arthritis. Br J Haematol, 1987, 66, 559-564
32. Hochberg MC, Arnold CM, Hogans BB, et al.- Serum immunoreactive erythropoietin in rheumatoid arthritis: Impaired response to anemia. Arthritis Rheum, 1988,31, 1318-1321
33. Miller CB, Jones RJ, Piantadosi S, Aet al.- Decreased erythropoietin response in patients witn the anemia of cancer. N Engl J Med, 1990,322, 1689-1692
34. Gasche C, Dejaco C, Reinisch W, et al.- Sequential treatment of anemia in ulcerative colitis with intraveinous iron and erythropoietin. Digestion, 1999, 60, 262-267
35. Boyd HK, Lappin TRJ.- Erythropoietin deficiency in the anemia of chronic disorder. Eur J Haematol, 1991, 46, 198-201
36. Gasche C, Waldhoer T, Feichtenschalgr T, Met al.- Prediction of response to iron sucrose in inflammatory bowel disease- associated anemia. Am J Gastroenterol, 2001,96,2382-2387
37. Yates P, Macht M, Williams NA, et al.- Red blood cell autoantibody production by colonic mononuclear cells from a patient with ulcerative colitis and autoimmune haemolytic anemia. Br J Haematol, 1992, 82, 753-756
38. Kaplinsky N, Frankl O.- Salicylazosulphapyridine-induced Heinz body anemia. Acta Haematol, 1978, 59, 310-314
39. Babbs C.- Oxygen radicals in ulcerative colitis. Free Radic Biol Med, 1992,13, 169-181
40. de Silva A, Mylonaki M, Rampton D.- Oral iron therapy in inflammatory bowel disease: usage, tolerance and efficacity. Inflammatory Bowel Disease, 2003, 9, 316-320
41. Gordeuk VR, Brittenham GM, Bravo J, et al.- Prevention of iron deficiency with carbonyl iron in female blood donors. Transfusions, 1990, 30, 239-245